User profiles for Marta Futema
 | Marta FutemaSt George's University of London Verified email at sgul.ac.uk Cited by 4945 |
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication …
BACKGROUND Familial hypercholesterolemia (FH) is an autosomal-dominant disorder caused
by mutations in 1 of 3 genes. In the 60% of patients who are mutation negative, we have …
by mutations in 1 of 3 genes. In the 60% of patients who are mutation negative, we have …
Genetic architecture of familial hypercholesterolaemia
M Sharifi, M Futema, D Nair, SE Humphries - Current cardiology reports, 2017 - Springer
Purpose of Review Familial hypercholesterolaemia (FH) is an inherited disorder of low-density
lipoprotein cholesterol (LDL-C) which is characterised by a raised cholesterol level from …
lipoprotein cholesterol (LDL-C) which is characterised by a raised cholesterol level from …
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
Background Familial hypercholesterolaemia is a common autosomal-dominant disorder
caused by mutations in three known genes. DNA-based cascade testing is recommended by …
caused by mutations in three known genes. DNA-based cascade testing is recommended by …
Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
Background Familial hypercholesterolaemia (FH) is an autosomal dominant disease of lipid
metabolism, which leads to early coronary heart disease. Mutations in LDLR, APOB and …
metabolism, which leads to early coronary heart disease. Mutations in LDLR, APOB and …
[HTML][HTML] Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital …
M Futema, RA Whittall, A Kiley, LK Steel, JA Cooper… - Atherosclerosis, 2013 - Elsevier
AIM: To determine the frequency and spectrum of mutations causing Familial Hypercholesterolaemia
(FH) in patients attending a single UK specialist hospital lipid clinic in Oxford and to …
(FH) in patients attending a single UK specialist hospital lipid clinic in Oxford and to …
UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits
We present and assess the UK Biobank (UKB) Polygenic Risk Score (PRS) Release, a set
of PRSs for 28 diseases and 25 quantitative traits being made available on the individuals in …
of PRSs for 28 diseases and 25 quantitative traits being made available on the individuals in …
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
…, M Lorenzini, M Futema… - European heart …, 2021 - academic.oup.com
Aims The aim of this study was to determine the frequency of heterozygous truncating ALPK3
variants (ALPK3tv) in patients with hypertrophic cardiomyopathy (HCM) and confirm their …
variants (ALPK3tv) in patients with hypertrophic cardiomyopathy (HCM) and confirm their …
The UCL low-density lipoprotein receptor gene variant database: pathogenicity update
S Leigh, M Futema, R Whittall… - Journal of Medical …, 2017 - jmg.bmj.com
Background Familial hypercholesterolaemia (OMIM 143890) is most frequently caused by
variations in the low-density lipoprotein receptor (LDLR) gene. Predicting whether novel …
variations in the low-density lipoprotein receptor (LDLR) gene. Predicting whether novel …
Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
Background Familial Hypercholesterolaemia (FH) is an autosomal dominant disease, caused
by mutations in LDLR, APOB or PCSK9, which results in high levels of LDL-cholesterol (…
by mutations in LDLR, APOB or PCSK9, which results in high levels of LDL-cholesterol (…
[HTML][HTML] Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
…, H Ashby, KE Shipman, JA Cooper, M Futema… - Atherosclerosis, 2017 - Elsevier
Background and aims Familial hypercholesterolemia (FH) is a common inherited disorder of
low density lipoprotein-cholesterol (LDL-C) metabolism. It is associated with higher risk of …
low density lipoprotein-cholesterol (LDL-C) metabolism. It is associated with higher risk of …
